.png)
.png)
Latest news from BIA
The public strongly agree that patients living with a rare disease should be able to equally access medicines on the NHS, new report reveals
The BIA has today launched a report Public attitudes to Rare Diseases: The case for equal access which presents the findings of a survey commissioned by the BIA on public attitudes towards rare diseases and access to medicine.
Instrumental figures in UK COVID-19 vaccine development recognised in Queen’s Birthday Honours 2021
The Queen’s Birthday Honours 2021 has been released with several UK biotech and life sciences figures receiving honours for their contributions to the UK’s response to the COVID-19 pandemic. Those receiving honours include: Kate Bingham, former Chair of the UK Vaccine Taskforce (VTF), has received a damehood Ian McCubbin, former Vaccine Manufacturing expert on the VTF, former VP of global supply for GSK and former chair of the BIA’s COVID-19 Vaccine Manufacturing Taskforce, has received a CBE Annette England (Netty), bioprocessing consultant for the BIA, has received an MBE
BIA reacts to publication of the 2021/22 Genome UK Implementation Plan
Steve Bates OBE, Chief Executive of the BIA said: "The UK has a long legacy in genomic research and the Government is right to build on our global competitive advantage by committing to a series of actions to begin to deliver on the ambitious vision set out in Genome UK. The UK is in a unique position globally to leverage our strong academic base and leadership in major initiatives such as the 100,000 Genomes Project to truly kick-start a world-leading genomics industry.
BIA welcomes fresh Biomedical Catalyst funding for UK biotech
The BIA has today welcomed the Government’s announcement that £18m will be invested in innovative UK life science companies through a relaunched Innovate UK Biomedical Catalyst competition.
NovaBiotics Announces Cysteamine Bitartrate (NM002) Included in REMAP-CAP Phase 3 Clinical Trial for Community Acquired Pneumonia
Randomized embedded multi-factorial platform trial to provide accelerated, real-world evidence in community acquired pneumonias including COVID-19, influenzas and bacterial pneumonias
Covington Advises Arecor Therapeutics on AIM IPO
LONDON, June 17, 2021 – Covington advised Arecor Therapeutics plc on the admission of its shares to trading on the AIM market of the London Stock Exchange. The IPO raised gross proceeds of £20 million through an oversubscribed placing of ordinary shares giving the company a market capitalisation of approximately £62.5 million.
Discovery Park announces appointment to new role of Chief Business Officer
Sandwich, Kent, June 15 2021 – Discovery Park, the Life Sciences Opportunity Zone for ambitious and growing life sciences companies, is pleased to announce the appointment of science park expert Jane Kennedy to the new role of Chief Business Officer (CBO).
Experienced regulatory professionals join the Boyds team
Leading pharmaceutical and biotech product development consultancy Boyds has added to its regulatory team with the appointments of Shalini Gupta and Sarah Stevenson in response to recent growth and the continued increase in demand for its dedicated regulatory services.
CEO Update | 21 June 2021
Following the Prime Minister’s announcement last Monday that COVID-19 restrictions were to be extended by a further four weeks in England, we have taken the difficult decision to postpone the BIA’s Garden Party. We hope to hold the event in person in September and we will share details once the new arrangements with the venue have been confirmed.
CEO update | 14 June 2021
I was delighted to read on Friday night that many colleagues and BIA members were rightly recognised in the Queen’s Birthday Honours List 2021. The headlines were dominated by Kate Bingham, former Chair of the UK’s Vaccine Taskforce (VTF) and Professor Sarah Gilbert of Oxford University who both became Dames.
CEO Update | 07 June 2021
Following a major campaign by the BIA to secure fresh funding for the Biomedical Catalyst, details of the new competition have gone live today on the Innovate UK website which can be found here.
CEO Update | 24 May 2021
Following a major campaign by the BIA to secure fresh funding for the Biomedical Catalyst, which many of you have supported, great news last week as the Government announced a £30m refill for a new round this year. Read our press release here and you can read more about the BIA’s decade-long campaign on the BMC, here.
Please find a selection of featured BIA publications below. To see our full publications library, click here.
Influencing and shaping our sector | BIA update: October 2019 - January 2020
This quarterly update gives an overview of key policy developments and the BIA’s continued engagement with policymakers, regulatory authorities and wider stakeholders on behalf of the UK life sciences sector, from October 2019 to January 2020.
Global and growing - UK biotech financing in 2019
New figures published today (Wednesday 22 January 2020) by the UK BioIndustry Association (BIA) and Informa Pharma Intelligence reveal that the UK biotech sector raised ÂŁ1.3 billion in 2019.
UK life sciences: Catalysing investment and growth
This updated interim report sets out how the UK life sciences sector is driving investment and growth and makes the case for increased cost-effective public investment in the sector.
BIA biotech manifesto 2019
The United Kingdom (UK) will have a general election on Thursday, 12 December. The UK BioIndustry Association (BIA) has launched a biotech manifesto with its recommendations on how political parties can support the innovative UK life sciences sector.Â
